These are taken daily and designed to deliver similar appetite-regulating effects as the injectable versions
GLP-1 therapies have demonstrated substantial weight-reduction benefits, with studies showing an average weight loss of 4.6 kg, a BMI reduction of 2.1 kg/m, and a decrease in waist circumference of 4.6 cm compared to placebo
doi: 10.1038/ijo.2016.93 4 ArnoldM.NhoK.Kueider-PaisleyA.MassaroT.HuynhK.BraunerB.et al
When it comes to regenerative peptides like GHK-Cu, quality is absolutely critical
A 2025 systematic review of 544 records found 35 preclinical and only 1 clinical study, and identified no clinical safety data
Sodium retention, edema, potassium excretion, and hypokalemic alkalosis